Cigna Group stock slips 2.64% and underperforms competitors
Updated
Updated · MarketWatch · May 1
Cigna Group stock slips 2.64% and underperforms competitors
10 articles · Updated · MarketWatch · May 1
Shares closed at $282.90 on Friday, extending losses to a second straight day as the S&P 500 rose 0.29% and the Dow fell 0.31%.
Cigna lagged rivals including UnitedHealth, CVS Health and Elevance Health, all of which also declined but by smaller percentages during the mixed session.
The stock finished 19.17% below its 52-week high of $350 reached on May 2, while trading volume of 1.5 million stayed below its 50-day average.
Why did Cigna’s stock drop sharply despite beating earnings estimates and raising its 2026 outlook—are investors more worried about regulatory risks or strategic shifts?
With AI adoption accelerating in healthcare, could Cigna’s tech investments outweigh concerns about thin margins and regulatory headwinds for future growth?